The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOX rechallenge versus regorafenib in patients with metastatic colorectal cancer refractory to standard chemotherapy: A retrospective analysis.
 
Maria Alessandra Calegari
No Relationships to Disclose
 
Ina Valeria Zurlo
No Relationships to Disclose
 
Brunella Di Stefano
No Relationships to Disclose
 
Floriana Camarda
No Relationships to Disclose
 
Carmela Di Dio
No Relationships to Disclose
 
Giovanna Garufi
No Relationships to Disclose
 
Alessandra Cassano
No Relationships to Disclose
 
Carlo Antonio Barone
Consulting or Advisory Role - SERVIER
Speakers' Bureau - Celgene; Merck Serono; MSD Oncology
Research Funding - Merck Serono (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck Serono; SERVIER
 
Emilio Bria
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Helsinn Healthcare; Lilly; MSD Oncology; Novartis; Pfizer; Roche (Inst)
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Michele Basso
No Relationships to Disclose
 
Armando Orlandi
No Relationships to Disclose